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Abstract
Background: Little is known about the impact of joining an Accountable Care Organization (ACO) on primary care
provider organization’s costs. The purpose of this study was to determine whether joining an ACO is associated
with an increase in a Rural Health Clinic’s (RHC’s) cost per visit.
Methods: The analyses focused on cost per visit in 2012 and 2013 for RHCs that joined an ACO in 2012 and cost
per visit in 2013 for RHCs that joined an ACO in 2013. The RHCs were located in nine states. Data were obtained
from Medicare Cost Reports. The analysis was conducted taking a treatment effects approach where the treatment
is joining an ACO. Propensity-score matching was employed to provide multiple single and pooled estimates of the
average treatment effect on the treated.
Results: Four-hundred thirty four to 544 RHCs (depending on the type of analysis and the variables used)
were used in the several analyses. Seven of the RHCs joined an ACO in 2012 and 14 joined an ACO in 2013.
The mean cost per visit for RHCs that did not join an ACO rose 4.40 % from 2011 to 2012 whereas the mean
cost per visit for RHCs that joined an ACO rose by triple: 13.5 %. All of the pooled estimates of the average
treatment effect on the treated from the propensity-score matching showed that joining an ACO was
associated with higher mean cost per visit. The range of the estimated mean cost per visit differences was
$17.19 (p value = 0.00) to $25.19 (p value = 0.00).
Conclusions: This study is one of the first to describe the cost of ACO participation from the perspective of
primary care provider organizations. It appears that for at least one type of primary care provider - the RHC -
there are substantial costs associated with ACO participation during the first two years.
Keywords: Accountable care organizations, Primary care, Costs, Average treatment effects
Background
The Accountable Care Organization (ACO) is one of the
new models of health care delivery that are intended to
shift the provision of health services from an emphasis
on volume to an emphasis on value. Whether the ACO
model is successful or not will be assessed based on its
achievement of two fundamental goals: 1) improvement
in the quality of care and health outcomes of the popula-
tion for which it is responsible, and 2) achievement of
cost savings by a reduction in avoidable hospitalizations
and emergency room visits via improving care coordin-
ation and preventive care services.
ACOs are composed of a range of health care organi-
zations such as hospitals, groups of doctors, and/or
other providers. In late 2011, CMS released regulations
regarding provider participation in ACOs. These regula-
tions included several provisions allowing primary care
providers such as Rural Health Clinics (RHCs) to join
Medicare Shared Savings Program (MSSP) ACOs, or to
organize with other RHCs to become their own ACOs.
Some of the RHCs that joined or formed MSSP ACOs
were also selected to participate in the Advance Payment
Model ACO, which was developed by CMS to meet the
needs of smaller ACOs, such as those composed of
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physician-based and rural providers. These Advance Pay-
ment Model ACOs were awarded payments to support
care coordination infrastructure. In this study we focus on
Rural Health Clinics to determine the cost implications of
ACO participation for rural primary care providers.
Recently, some findings of the impact of ACOs on
costs per capita are beginning to emerge [1–3]. In
addition, estimates of startup and first-year costs of
forming an ACO have been made by both CMS and in-
dependent researchers (e.g., [4]). However, few studies
examine the costs of a healthcare organization’s joining
an ACO, and fewer still report on the costs associated
with a primary care organization’s joining an ACO. To
date, to the best of our knowledge, there have been no
published findings on the costs to RHCs of ACO partici-
pation. Consequently, there is a strong need to investi-
gate the costs incurred when primary care providers
(organizations) such as RHCs join an ACO. Further-
more, there is an intriguing feature of cost per visit data
for RHCs for the period 2007 through 2012 that we
analyze here.1
We discovered that mean annual cost per visit for
those RHCs that joined an ACO in 2012 jumped from
2011 to 2012 much more than for the other RHCs. Spe-
cifically, the rise for the ACO RHCs was bigger than for
the others both in absolute terms ($15 per visit vs. $5
per visit) and in percentage term compared to the previ-
ous year (13.5 % higher than 2011 vs. 4.4 % higher than
2011.) See the Results section for more details.
These results raise a question: “Could the bigger jump
in cost per visit for the ACO RHCs be due to joining an
ACO?” In light of the above, the purpose of this study is
to determine the relationship between ACO participa-
tion and cost per visit from the perspective of primary
care providers. It is important to understand the cost of
transitioning to and participating in ACOs from their
perspective so that primary care providers may better
plan for the future and remain viable in the evolving
health care environment.
Review of the literature
The transformation of our current volume-based pay-
ment system to one that is value-based will result in sav-
ings of $55 billion over 5 years for Medicare alone,
according to CMS officials [5]. There are some indica-
tions that Medicare ACOs will achieve cost savings,
although they may not do so initially. In their study of
the Medicare Physician Group Practice (PGP) demon-
stration program (Medicare’s first physician pay-for-
performance initiative), Pope et al. [6] determined that it
is unlikely that Medicare ACOs will achieve large savings
in the early stages of formation. Medicare beneficiaries
aligned with the Pioneer Accountable Care Organization
model were associated with smaller increases in total
Medicare expenditures [7], or modest reductions in
Medicare spending [8]. The Pioneer ACO program over-
all achieved a total savings of $87.6 million [9]. Else-
where, Epstein et al. [10] compared patients cared for by
Medicare ACOs to non-ACO patients, matched by geo-
graphic location, demographic, socioeconomic, and clin-
ical characteristics. The results were lower inpatient,
nonhospital and total costs for the ACO patients.
We know little about the initial and ongoing costs that
primary care providers may incur should they choose to
participate in ACOs. In fact, to the best of our know-
ledge, there have been no published findings on the
costs to RHCs of ACO participation. The operating costs
of providers that transform to Patient-Centered Medical
Homes (PCMHs) may provide a hint of what providers
can anticipate as they transition to become ACO partici-
pants. PCMHs share many of the same characteristics as
ACOs, including patient-centeredness, population health
management, care coordination, and the use of certified
EHR technology.
Most studies of costs associated with PCMHs describe,
rather than quantify, the costs of transitioning to PCMHs.
Reiter et al. [11] describe costs as falling into two categor-
ies: costs of personnel time for transformation-related ac-
tivities, and non-personnel resource costs such as for IT
and supplies. Of the few studies that quantify costs, Nocon
et al. [12] determined that Federally Qualified Health Cen-
ters that have a greater number of attributes associated
with a PCMH had higher operating costs.
Methods2
Data sources and variables
The study population consisted of a panel of RHCs con-
tinuously operating during 2007–2013 as reported in the
Center for Medicare and Medicaid Service’s (CMS’s)
Online Survey, Certification and Reporting (OSCAR)
database [13]. These RHCs were located in nine states:
Alabama, California, Florida, Georgia, Kentucky,
Mississippi, North Carolina, South Carolina, and Ten-
nessee. Other sources of data were the Medicare Cost






vestigators completed data management training regard-
ing the protection of data and of human subjects. A data
use agreement concerning the use of the Cost Report
data was approved by the Centers for Medicare and Me-
dicaid Services. Approval for the investigation was ob-
tained through the Institutional Review Board of the
University of Central Florida.
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The study sample was composed of the 7 RHCs that
joined MSSP ACOs in 2012, an additional 14 RHCs that
joined in 2013, and the remaining RHCs that did not join
an ACO. Among the total 21 RHCs in the sample were 11
that participated in Advance Payment Model ACOs.
The Medicare Cost Reports were the source of data
for the study variables. The Medicare Cost Report is an
annual cost report that Medicare-certified RHCs are re-
quired to submit to CMS or a Medicare Administrative
Contractor. Although the cost report is limited in regard
to some details of clinic operation, it is the most
complete source of available data for RHCs at this time.
The dependent variable was “cost per visit” (total cost of
health care services + total nonreimbursable costs + total
facility overhead)/ total visits provided to all patients by
physicians, physician assistants, nurse practitioners,
visiting nurses, and clinical social workers. The inde-
pendent variables were: “TotFTE” (size of the RHC mea-
sured as the sum of the FTEs of physicians + physician
assistants + nurse practitioners), “Provbsd” (a dummy
variable where 1 = provider-based RHC and 0 = independ-
ent RHC), “Control” (classification of organizational control
as for-profit, non-profit, or government), “Age” (number of
years Medicare certified for participation in RHC program),
and “Rural” (a dummy variable where 1 = RHC located in
an isolated location and 0 = otherwise3) [16].
Introduction: treatment effects estimation
We will be viewing participating in a Medicare Shared
Savings Program ACO as a “treatment” and will, there-
fore, estimate the treatment effect of joining an ACO.
Treatment-effect estimators allow us to estimate three
parameters. The potential-outcome means (POMs) are
the means of Y1 (the potential outcome of a subject that
did not receive treatment had it been treated) and Y0
(the outcome of a treated subject had it not received the
treatment) in the population. The average treatment ef-
fect (ATE) is the mean of the difference (Y1 - Y0) for all
subjects – those that received the treatment and those
that did not. Finally, the average treatment effect on the
treated (ATET) is the mean of the difference (Y1 - Y0)
among only the subjects that actually received the treat-
ment. We will report results for only the ATET for rea-
sons described below in the Results section.
Matching
Matching estimators are based on the idea of comparing
the outcomes of subjects that are as similar as possible
with the sole exception of their treatment status. One of
the most widely-used methods to find comparable obser-
vations is propensity-score matching (PSM). PSM
matches on the estimated predicted probabilities of
treatment, known as the propensity scores.
Finding multiple controls for each treated subject
Matching each treated subject with one other control
subject is the most common behavior in most match-
ing studies. However, you can match each treated
subject with multiple control subjects with the oppos-
ite treatment level. It is important to be clear about
the benefits and costs of multiple matching. Matching
on more distant neighbors can reduce the variance of
the estimator at a cost of a possible increase in bias.
However, as you match more controls with each
treated subject, you are finding successively poorer
matches. Whether or not this becomes a problem
(and if so, how big a problem) depends on how much
worse the matches become as the number of matches
per treated subject rises.
Our dataset contains three subsamples: (i) 2012 data
for the 7 RHCs that joined an ACO in 2012, (ii) 2013
data for the 7 RHCs that joined an ACO in 2012, and
(iii) 2013 data for the 14 RHCs that joined an ACO in
2013. We match each treated subject (an RHC that
joined an ACO) with different numbers of control sub-
jects (RHCs that did not join an ACO.) The number of
matches (M) equals 1, 2, 3, 4, or 5.
We take three estimation paths. One involves separ-
ately estimating the effect of ACO participation on cost/
visit for subsamples (i) and (ii) above. This permits us to
determine whether or not the effect of ACO participa-
tion on cost/visit changed from 2012 to 2013. The sec-
ond path estimates the treatment effect of ACO
participation on the combined years of 2012 and 2013
for the 7 RHCs, a T = 2 panel. This allows us to account
for unobserved time-constant confounders. Last, we esti-
mate the treatment effect on subsample (iii) above,
handling it as a single cross section.
There are five different ATET estimates in every one
of the analyses covered in the previous paragraph. That
is, we estimate ATET for M (number of controls
matched with each treated RHC) = 1, then M = 2, then
M = 3, then M = 4, and finally M = 5. One common way
to learn the overall lesson from multiple studies is to use
meta-analysis methods. We will regard each analysis that
yielded an estimated ATET (one per value of M) as a
“study” and use the Manzel-Haenszel (1959) [17] fixed
effects method to uncover the general ATET on cost/
visit of joining an ACO. Doing so has the advantages of
employing a credible and widely-used method for com-
bining multiple results and avoids making arbitrary deci-
sions about which of the five estimates (M = 1, 2, 3, 4, 5)
to report from each analysis.
Results
In the Background section we mentioned the dis-
similar increases in cost per visit for RHCs that
joined an ACO in 2012 compared to those that did
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not. Table 1 shows both the mean and percentage
change in cost per visit for the 7 RHCs that joined
an ACO in 2012 and those RHCs that did not. No-
tice that cost-per-visit values are relatively stable for
the ACO RHCs – until 2012. There is a jump in
cost/visit in 2012 for both groups of RHCs from
2011 to 2012. However, the rise for the ACO RHCs
is bigger than for the others both in absolute terms
($15 per visit vs. $5 per visit) and in percentage
terms in two ways: compared to the mean cost per
visit for 2007 through 2011 (9.0 % higher than the
mean vs. 4.8 % higher) and compared to the previ-
ous year (13.5 % higher than 2011 vs. 4.4 % higher
than 2011.) This motivates our analysis.
That analysis is accomplished in two steps.
Step 1: Estimate propensity scores
Propensity-score matching (PSM) matches on the pre-
dicted probabilities of treatment, known as the pro-
pensity scores. One estimates either a logit or probit
model with the dependent variable being the treat-
ment binary variable. In this case, the dependent vari-
able is equal to 1 if the RHC joined an ACO and
equals zero otherwise. The predicted probabilities of
joining an ACO are the propensity scores in this
study. Our logit model contains the major variables
that the literature says will influence the decision to
join an ACO and that we have in our dataset. Those
variables are “size” of the RHC (as measured by the
total FTEs, or full-time equivalents, for the RHC),
and “rural” (as measured by the RUCA codec for the
RHC). Previous research has indicated that the size of
physician practices is positively related to ACO par-
ticipation [18], and that RHC size was positively re-
lated to an RHC’s willingness to join an ACO [19]. In
regard to geographic location, RHCs located in iso-
lated areas were 78 % less likely to be in ACOs than
those located in areas with a RUCA classification of
“urban” [19].
Table 2 contains the estimation results for the logit
model from which propensity scores are estimated.
Only the rurality variable appears to affect the likeli-
hood that an RHC joins an ACO. It says that being
in an isolated location reduces the likelihood that an
RHC will join an ACO.
Step 2: Estimate average treatment effect on the treated
(ATET) using propensity-score matching
Recall from the Methods section that the average treat-
ment effect (ATE) is the mean of the difference (Y1 - Y0)
for all subjects – those that received the treatment and
those that did not. The average treatment effect on the
treated (ATET) is the mean of the difference (Y1 - Y0)
among only the subjects that actually receive the treat-
ment. We estimate the ATET for the following reasons:
The ATET tells us whether a particular treatment is
beneficial only for those who were in the treatment
group. RHCs and other providers participate in ACOs
for several reasons. They evaluate not only the bene-
fits of participating in an ACO such as possible
improvement in patient outcomes, but also the draw-
backs such as the start-up costs. In addition to such
evaluation, a provider’s decision to become part of or
form an ACO is inevitably influenced by the actions
of its peers. RHC management are very interested in
how their peers fare in this new ACO model. In other
words, they are most interested in the experiences of
the RHCs that participated in an ACO so they can
decide about their RHC joining or forming an ACO.
Thus, for this study that concerns strategic decisions
of providers rather than clinical treatment decisions,
we have chosen to estimate a treatment effects meas-
ure (the ATET) that shows how only those RHCs that
participated in an ACO fared instead of ATE, which
shows how all RHCs could have done (whether they
were actually in an ACO or not).
Table 3 contains the results from the analyses of four
subsamples. They are as follows:
Table 1 Mean and percentage changes: cost/visit for the 7
RHCs that joined ACOs in 2012 and those that did not
Cost per visit Cost per visit
RHCs in ACO in 2012 RHCs not in ACO in 2012
mean % change mean % change
2007 $119 $118
2008 116 −2.50 % 107 −9.30 %
2009 116 0.00 % 116 8.40 %
2010 116 0.00 % 113 −2.60 %
2011 111 −4.30 % 114 0.90 %
2012 126 13.50 % 119 4.40 %
Table 2 Logit model used to generate propensity scores.
Dependent variable is ACO Start12 = 1 if RHC joined an ACO in
2012 or in 2013
Predictor β
Size (Total FTEs) −0.388 (0.315)
Provider-based RHC 0.914 (0.400)
Control −0.208 (0.469)








** p < 0.05
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i. Part 1: A single cross-section for 2012 and the 7
RHCs that joined an ACO in 2012
ii. Part 2: A single cross-section for 2013 and the 7
RHCs that joined an ACO in 2012
iii. Part 3: A single cross-section for 2013 and the 14
RHCs that joined an ACO in 2013
iv. Part 4: A T = 2 panel for 2012 and 2013 and the 7
RHCs that joined an ACO in 2012.
Table 3 Estimated ATET by number of matches and pooled across the different numbers of matches. Year = 2013 and 7 RHCs that
joined an ACO in 2012
Study ATET [95 % Conf. Interval] % Weight
Part 1 (Year is 2012 and the 7 RHCs that joined an ACO in 2012, n = 544)
Test of ATET = 0: z = 6.68, p = 0.000
Matches = 1 26.740 8.022 45.458 15.61
Matches = 2 29.410 11.653 47.167 17.34
Matches = 3 26.610 8.931 44.289 17.50
Matches = 4 23.040 8.066 38.014 24.39
Matches = 5 22.430 7.691 37.169 25.17
Pooled ATET (note 1) 25.193 17.799 32.588 100.00
Percentage of mean 14.02 %
Part 2 (Year is 2013 and the 7 RHCs that joined an ACO in 2012, n = 435)
Test of ATET = 0: z = 3.17, p = 0.002
Matches = 1 14.110 −10.488 38.708 18.81
Matches = 2 19.790 −5.592 45.172 17.67
Matches = 3 18.450 −5.030 41.930 20.65
Matches = 4 16.980 −6.285 40.245 21.03
Matches = 5 17.170 −5.664 40.004 21.83
Pooled ATET (note 1) 17.282 6.612 27.951 100.00
Percentage of mean 14.02 %
Part 3 (Year is 2013 and the 14 RHCs that joined an ACO in 2013, n = 434)
Test of ATET = 0: z = 3.73, p = 0.000
Matches = 1 27.590 0.621 54.559 17.60
Matches = 2 23.840 −2.267 49.947 18.78
Matches = 3 20.180 −5.535 45.895 19.36
Matches = 4 17.740 −5.976 41.456 22.76
Matches = 5 19.850 −4.552 44.252 21.50
Pooled ATET (note 1) 21.545 10.231 32.859 100.00
Percentage of mean 17.48 %
Part 4 (Panel for 2012 and 2013 and the 7 RHCs that joined an ACO in 2012, n = 984)
Test of ATET = 0: z = 5.12, p = 0.000
Matches = 1 13.490 −3.189 30.169 15.57
Matches = 2 17.020 3.300 30.740 23.02
Matches = 3 16.320 2.581 30.059 22.95
Matches = 4 19.670 4.441 34.899 18.68
Matches = 5 18.940 4.142 33.738 19.78
Pooled ATET (note 1) 17.185 10.603 23.766 100.00
Percentage of mean 14.05 %
Note 1: Employing the meta-analysis fixed effect model using the method of Mantel and Haenszel, 1959 [19]
Note 2: Mean cost/visit = $121.43 (2012), $123.29 (2013), and $122.36 (2012 and 2013)
Note 3: Panel 4 shows the results of using the fixed effects model (the within transformation) for a T = 2 panel. This is not the same as the fixed effect model used
in the Mantel-Haenszel method
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Most of the columns of each panel are self-
explanatory. The column on the far right of each panel
shows the contribution of each row (“study”) to the
overall pooled ATET estimate.
The ATET estimates in Part 1 (2012) range from
$22.42 (M = 5) to $29.41 (M = 2.) All of the estimated
treatment effects of joining an ACO are significantly dif-
ferent from zero at the 5 % level or better. The pooled
ATET estimate (combining all five of the estimates) is
$25.19 and is significantly different from zero (z = 6.68
and p = 0.000.) The ATET estimates in Part 2 (2013) are
uniformly lower than those in Part 1. All of the esti-
mated ATET values are significantly different from zero
at the 5 % level or better. The pooled ATET estimate is
$17.28 (also lower than in Panel 1) and is significantly
different from zero (z = 3.17 and p = 0.002).
Part 3 shows the results for the 14 RHCs that joined
an ACO in 2013. Their pooled ATET estimate is lower
than the first-year pooled ATET estimate for the RHCs
that started in an ACO in 2012. It is $21.55 (vs. $25.19
for the 2012 RHCs) and is significantly different from
zero (z = 3.73 and p = 0.000).
These results in Parts 1–3 suggest several points. First,
joining an ACO does raise cost/visit. Second, the jump
in cost can be substantial, with point estimates ranging
from 14 % to nearly 21 %. Third, that increase lasts at
least two years. Fourth, the rise seems to be less in the
second year.
Finally, Part 4 contains the panel data (T = 2 years) es-
timates of the ATET for those RHCs that began in an
ACO in 2012. We employed the fixed effects model
(using the within transformation) for this short panel.
The pooled ATET estimate is $17.18 and is significantly
different from zero (z = 5.12 and p = 0.000).
Notice that the pooled ATET estimate for 2012 and
2013 combined (Table 3, Part 4) is $0.10 lower than the
pooled ATET estimate for 2013 ($17.18 vs. $17.28) and
is $8.01 lower than the pooled ATET estimate for 2012
($17.18 vs. $25.19.) In other words, the estimate for
2012 and 2013 combined is lower than the lower esti-
mate for either single year. This could be due to the fact
that the method for estimating the single-year ATET
values ignores time-constant unobserved factors (called
unobserved heterogeneity or fixed effects or con-
founders) whereas the fixed effects estimator accounts
for them. Time-constant (over 2012 and 2013) unob-
served factors that might affect cost/visit include busi-
ness goals of the clinic’s decision-makers,4 demographic
factors of the community not captured in our data, and
features of the local environment that can make doing
business either cheaper or more costly. Evidently, these
unobserved factors raised cost/visit during 2012 and
2013. Adjusting for them subtracts their impacts on
cost/visit from the estimated ATET to give an estimated
treatment effect that is closer to the true impact on
cost/visit of joining an ACO.
Discussion
This study was an examination of the impacts on costs
of RHCs using a treatment effects approach where the
treatment was joining an ACO. The results suggest sev-
eral points. First, joining an ACO does raise cost/visit.
Second, the jump in cost can be substantial, with point
estimates ranging from 14 % to nearly 21 %. Third, that
increase lasts at least two years. Fourth, the rise seems
to be less in the second year.
While an investigation of the contributors to the
change in costs is beyond the scope of this study, we can
speculate about some of those factors. Although RHCs
may receive a federal incentive grant to support starting
an ACO, establishing and sustaining the necessary ACO
infrastructure can be costly. In a recent study of the
early experiences of RHCs that participate in ACOs, sev-
eral reported that building the necessary infrastructure
means added costs related to administration, electronic
health record (EHR) system establishment and mainten-
ance, and often, additional staff to meet new regulatory
or quality expectations [20].
EHR systems are a fundamental feature of ACO
organizational structure. By sharing patient data among
the participant providers of the ACO, EHR is expected
to improve patient quality of care and health outcomes.
The initial costs of EHR implementation can be high,
however, and even if ACO participants have EHR in
place, their software systems may be incompatible.
Other costs are associated with important but labor-
intensive activities such as obtaining patient consent to
collect data. Once collected, Medicare ACOs require
that the data be compiled, analyzed, and submitted. Sev-
eral hours per month may be spent in such required
committees as finance, quality care, and EHR.
Enforcing standards of quality for ACOs can also be
costly. Medicare ACOs use 33 quality measures classi-
fied in four domains: patient experience, coordination of
care and patient safety, preventative health, and caring
for at-risk populations [21]. Additional costs for training
and monitoring for quality improvement efforts can be
incurred.
There are several policy considerations concerning the
participation of RHCs and other primary care providers
in ACOs. Needed are more clear guidelines regarding
the expectations of primary care providers with limited
administrative infrastructures such as those common to
RHCs. Consideration must be given to the demographic
makeup and limited clinical workforce of small rural
communities. Although ACO design and participant re-
quirements will continue to evolve, this model has many
anticipated benefits to patients, providers, and the
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healthcare delivery system as a whole. Patients are ex-
pected to benefit from improved continuity of care and
greater access to preventive care. Primary care providers
could benefit from having greater access to capital for
training, hiring or sharing staff, and developing techno-
logical infrastructure. Finally, ACOs are anticipated to
reduce healthcare costs overall by reducing emergency
department visits and hospitalizations.
Limitations
Although the results uniformly show that joining an
ACO does raise cost/visit, there are a few limitations to
this study. First, although there exist several types of
both Medicare and commercial ACOs in the current
healthcare environment, our data were limited to RHCs
participating in Medicare Shared Savings Program (MSSP)
ACOs (which included Advance Payment Model ACOs).
Second, the analyses were limited to RHCs in nine states
only, and do not necessarily represent the changes in cost
associated with ACO participation for RHCs in other
areas of the U.S. Third, in selecting variables for the logit
model to create a comparison sample for predicting ACO
participation, we were limited to the available data. These
data did not allow us to create other variables associated
with ACO participation by physician practices, such as
PCMH recognition [18]. Fourth, although several cost
components were included, the specific cost components
which may have contributed to the cost increase were not
analyzed in this study. Finally, in part because it is early in
the history of ACOs (the first MSSP ACOs were an-
nounced in January of 2012), the number of RHCs partici-
pating in ACOs is low. As a consequence, the analysis is
based on a dataset that contains just twenty-one RHCs
that joined an ACO. Keep in mind, though, that the smal-
lest subsample had 434 observations (see Table 3) due to
the large number of non-ACO RHCs in our dataset.
Despite these limitations, this study has value in
describing changes in costs of some primary care
providers during the early years of their participation
in ACOs. From a practical standpoint, providers that
are considering ACO participation need to be able
to anticipate and budget for additional personnel, in-
formation technology, supplies-related expenses, and
the like associated with the transition. The costs of
preparing and maintaining the infrastructure neces-
sary for ACO participation may diminish over time.
It is also likely that the costs will vary depending on
the length of time the provider has participated in
an ACO. Additionally, this study has intentionally ig-
nored the benefits during the first year of ACO par-
ticipation. So, this study necessarily presents only
part of the entire picture of the changes that can
occur as a result of ACO participation.
Conclusions
While it is early in ACO history to draw conclusions
about the impact of ACO participation on the cost of
healthcare per capita, this study is one of the first to de-
scribe the cost of ACO participation from the perspec-
tive of primary care provider organizations. It appears
that for at least one type of primary care provider
organization – the RHC – there are substantial costs as-
sociated with ACO participation during the first two
years. Future studies will examine not only the costs re-
lated to ACO participation over a longer period, but also
the factors that may contribute to those costs. Add-
itional evidence is needed concerning the most success-
ful ACOs that include rural providers, as well as those
composed entirely of rural providers.
Endnotes
1We are investigating only those RHCs in Alabama,
California, Florida, Georgia, Kentucky, Mississippi,
North Carolina, South Carolina, and Tennessee. Seven
RHCs in these states joined an ACO in 2012 and 14
joined in 2013, the most recent data that are available.
2Some of this section contains parts of an introduction
to treatment effects estimation contained in the Stata 13
documentation: “teffects intro—introduction to treat-
ment effects for observational data” in the Stata docu-
mentation for the teffects command.
3The Rural–urban Commuting Area (RUCA) Code
has four categories: 1 = Urban, 2 = Large rural, 3 = Small
rural, and 4 = Isolated. This binary variable “rural” equals
one for each RHC with a RUCA code equal to 4. We
chose this specification for this binary variable because
our analysis of survey responses we received showed that
RHCs in isolated areas are less likely to join ACOs.
4These might include cost minimization, increasing
market share, improving patient care at higher costs, etc.
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